Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection
Emerging biomarker platforms, including microRNA profiling and high-throughput proteomic and lipidomic signatures, together with advanced imaging approaches such as MRI-visible nano-GLP-1RA formulations, provide novel tools to monitor molecular and spatial drug effects in vivo
Constipation, travel, lower activity, missed doses, stress, sleep disruption, or a new strength routine can all affect scale movement
Its part of the mechanism behind the effectiveness of these drugs to contribute to a reduced appetite
And supplementation should always complement a healthy, well-rounded diet
Read more: Im an obesity medicine doctor and Ive been on weight-loss drugs like Ozempic for a decade